Carregant...
EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS
Despite advances in the pathological understanding of eosinophilic esophagitis (EoE), as of yet no single agent has been approved by the Food and Drug Agency to treat EoE. Off-label, EoE is currently treated by the three D’s, which are drugs (particularly swallowed topical corticosteroids), dietary...
Guardat en:
| Publicat a: | J Allergy Clin Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6981295/ https://ncbi.nlm.nih.gov/pubmed/31705907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.10.027 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|